Regulations.gov document

Determination of Regulatory Review Period for Purposes of Patent Extension; AMPLATZER…

Notice · FDA-2022-E-0661 · posted Feb 29, 2024

Key facts

Document ID FDA-2022-E-0661-0006
Title Determination of Regulatory Review Period for Purposes of Patent Extension; AMPLATZER AMULET
Document type Notice
Subtype Determinations
Agency FDA
Docket FDA-2022-E-0661
Posted Feb 29, 2024
Federal Register citation 89 FR 14885
FR document number 2024-04206
Comment period opens Feb 29, 2024
Comments due Apr 30, 2024
Effective date Feb 29, 2024

At a glance

  • 1–9 Pages
  • No Open for comment
  • None Public comments on this docket

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Regulations.gov documents

Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.

Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date:

Browse all Regulations.gov documents